Matsuyama T, Awazu M, Oikawa T, Inatomi J, Sekine T, Igarashi T
Department of Pediatrics, Fussa Hospital, Fussa City, Tokyo, Japan.
Clin Nephrol. 2004 Apr;61(4):231-7. doi: 10.5414/cnp61231.
Dent's disease is an X-linked renal tubular disorder characterized by low-molecular-weight-proteinuria, hypercalciuria, nephrolithiasis and renal failure. The disease is due to inactivation of a renal chloride channel gene, CLCN5. We have investigated 3 unrelated Japanese families for CLCN5 mutations and assessed the carrier mothers biochemically and ultrasonogaraphically to ascertain whether these clinical examinations can predict the carrier state of the disease.
Twelve members from these families were studied biochemically and ultrasonographically. Leukocyte DNA from probands was used with CLCN5-specific primers for PCR amplification of the coding region and exon-intron boundaries, and the DNA sequences of the products determined to identify abnormalities in the gene.
Three novel CLCN5 mutations consisting of a single base "A" insertion between nucleotides 590 and 591, a nonsense mutation (R28X) and a missense mutation (G506R) were exhibited. Hypophosphatemia was detected in 2 patients, beta2-microglobulinuria, alpha1-microglobulinuria, and hyperretinol binding proteinuria in 6 patients, hypercalciuria in 5 patients, decreased urine osmolality in 3 patients, and nephrocalcinosis or nephrolithiasis in 4 patients. Biochemical analysis of the urine and the renal ultrasonography in each carrier mother were completely normal.
Neither urinary low-molecular-weight-proteins, urinary calcium to creatinine ratio, nor renal ultrasonography was predictive of carrier state in the 3 families with this disease, although each carrier mother had CLCN5 mutation. Hypophosphatemia and decreased urine osmolality might be a hint to suspect the carrier state of Dent's disease, although these findings are not found frequently.
丹特病是一种X连锁肾小管疾病,其特征为低分子量蛋白尿、高钙尿症、肾结石和肾衰竭。该疾病是由于肾氯通道基因CLCN5失活所致。我们对3个无亲缘关系的日本家庭进行了CLCN5突变研究,并对携带致病基因的母亲进行了生化和超声检查,以确定这些临床检查能否预测该疾病的携带状态。
对这些家庭的12名成员进行了生化和超声检查。使用先证者的白细胞DNA和CLCN5特异性引物对编码区和外显子-内含子边界进行PCR扩增,并对产物的DNA序列进行测定,以鉴定基因异常。
发现了3种新的CLCN5突变,分别为590和591核苷酸之间单个碱基“A”插入、无义突变(R28X)和错义突变(G506R)。2例患者检测到低磷血症,6例患者检测到β2-微球蛋白尿、α1-微球蛋白尿和视黄醇结合蛋白尿增多,5例患者检测到高钙尿症,3例患者尿渗透压降低,4例患者有肾钙质沉着症或肾结石。每位携带致病基因母亲的尿液生化分析和肾脏超声检查均完全正常。
在这3个患有该疾病的家庭中,尽管每位携带致病基因的母亲都有CLCN5突变,但尿低分子量蛋白、尿钙与肌酐比值以及肾脏超声检查均不能预测携带状态。低磷血症和尿渗透压降低可能提示怀疑丹特病的携带状态,尽管这些发现并不常见。